Rapport Therapeutics

Rapport Therapeutics is a clinical-stage biotechnology company dedicated to the discovery and development of precision medicines for neurological disorders. Rapport Therapeutics leverages discoveries from its scientific founders to identify receptor-associated proteins, enabling the identification of precisely targeted small-molecule drugs with the potential to transform the treatment of neurological diseases. Its lead program is currently in Phase 1 studies for the treatment of drug-resistant epileptic seizures.